Metraipolis › archive › dc_e4c1c09caec2

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42194809
DOI
10.3390/jcm15103850
License (as archived)
solo-consultazione
Archived
2026-11-01T16:16:13.901Z
SHA-256 of the archived text
31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0
Stable URL of this page
https://metraipolis.com/documento/dc_e4c1c09caec2

How to cite

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809 — Europe PMC (en), https://europepmc.org/article/MED/42194809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4c1c09caec2 (Metraipolis archive dc_e4c1c09caec2, sha256 31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0)
BibTeX
@misc{dce4c1c09caec2,
  title = {Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4c1c09caec2; sha256 31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194809. Agents can read the archived copy with the MCP tool read_document.